IMBRIANO, Carol
 Distribuzione geografica
Continente #
NA - Nord America 12.384
AS - Asia 6.338
EU - Europa 5.767
SA - Sud America 921
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 146
OC - Oceania 81
Totale 25.833
Nazione #
US - Stati Uniti d'America 12.112
SG - Singapore 1.998
IT - Italia 1.986
CN - Cina 1.598
GB - Regno Unito 1.238
HK - Hong Kong 764
BR - Brasile 698
VN - Vietnam 690
SE - Svezia 649
DE - Germania 384
BD - Bangladesh 323
FR - Francia 281
FI - Finlandia 237
RU - Federazione Russa 234
KR - Corea 182
UA - Ucraina 172
IN - India 165
ID - Indonesia 124
CA - Canada 123
TR - Turchia 113
JP - Giappone 93
MX - Messico 90
AR - Argentina 84
NL - Olanda 82
AU - Australia 80
BG - Bulgaria 72
ES - Italia 71
CZ - Repubblica Ceca 63
BE - Belgio 51
ZA - Sudafrica 50
PL - Polonia 46
IQ - Iraq 39
LT - Lituania 39
EC - Ecuador 36
IE - Irlanda 33
CO - Colombia 30
AE - Emirati Arabi Uniti 27
AT - Austria 27
MY - Malesia 24
PK - Pakistan 24
UZ - Uzbekistan 24
EG - Egitto 22
MA - Marocco 22
CH - Svizzera 20
SA - Arabia Saudita 20
CL - Cile 19
PH - Filippine 17
VE - Venezuela 16
PY - Paraguay 15
TW - Taiwan 15
CR - Costa Rica 12
DZ - Algeria 11
TH - Thailandia 11
TN - Tunisia 11
UY - Uruguay 11
IL - Israele 10
IR - Iran 10
PT - Portogallo 10
ET - Etiopia 9
JO - Giordania 9
KE - Kenya 9
LB - Libano 9
NP - Nepal 9
PE - Perù 9
AL - Albania 8
RS - Serbia 8
GR - Grecia 7
JM - Giamaica 7
NI - Nicaragua 6
RO - Romania 6
SI - Slovenia 6
AZ - Azerbaigian 5
BY - Bielorussia 5
SN - Senegal 5
BB - Barbados 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GE - Georgia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
LV - Lettonia 4
PA - Panama 4
PR - Porto Rico 4
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
BZ - Belize 3
CI - Costa d'Avorio 3
EU - Europa 3
HN - Honduras 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 25.612
Città #
Ashburn 1.370
Singapore 1.221
Santa Clara 1.123
Fairfield 1.033
Southend 742
Hong Kong 738
Woodbridge 649
San Jose 592
Chandler 584
Hefei 509
Houston 435
Council Bluffs 434
Seattle 384
Ann Arbor 375
Modena 365
Cambridge 348
Wilmington 340
Nyköping 303
Jacksonville 293
Beijing 277
Dearborn 249
Los Angeles 245
London 221
New York 214
Ho Chi Minh City 212
Milan 194
Bologna 173
Hanoi 169
The Dalles 165
Seoul 163
Helsinki 136
Chicago 135
San Diego 98
Jakarta 95
Reggio Emilia 91
Munich 81
Lauterbourg 77
Moscow 73
Shanghai 72
Tokyo 72
Buffalo 70
Princeton 69
São Paulo 68
Sofia 66
Dallas 62
Parma 59
Eugene 58
Columbus 57
Izmir 52
Phoenix 52
Bremen 50
Orem 48
Rome 46
Dong Ket 45
Brno 44
Salt Lake City 44
Brussels 41
Fremont 41
Mexico City 40
Boardman 38
Turku 38
Warsaw 38
Da Nang 37
Denver 36
Frankfurt am Main 36
Montreal 34
Brooklyn 33
Poplar 30
Atlanta 29
Durham 29
Johannesburg 29
Chennai 28
Redwood City 28
Toronto 28
Formigine 27
Mumbai 27
Stockholm 27
Dublin 25
Kent 25
Naples 25
Turin 25
Des Moines 24
Falls Church 24
Paris 24
Tampa 24
Amsterdam 23
Elk Grove Village 23
Haiphong 23
Tashkent 23
Baghdad 21
Norwalk 21
Rio de Janeiro 21
Belo Horizonte 20
Guangzhou 19
Medesano 19
Nuremberg 19
San Francisco 18
Brasília 17
Florence 17
Boston 16
Totale 17.130
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 482
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 454
Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters 442
An autoregulatory loop controls the expression of the transcription factor NF-Y 431
Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells 422
NF-YA splice variants have different roles on muscle differentiation 420
NF-Y splice variants differentially affect skeletal myogenesis 416
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 409
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 391
Direct non transcriptional role of NF-Y in DNA replication 390
Curcumin derivatives: molecular basis of their anti-cancer activity. 388
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 384
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 376
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 374
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 371
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 370
NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s 368
NF-Y activates genes of metabolic pathways altered in cancer cells 360
bis-Dehydroxy-Curcumin Triggers Mitochondrial-Associated Cell Death in Human Colon Cancer Cells through ER-Stress Induced Autophagy. 359
The NF-Y/p53 liaison: Well beyond repression. 353
Alternative splicing of transcription factors genes in muscle physiology and pathology 350
Cloning and characterization of the histone-fold proteins YBL1 and YCL1 349
Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2 344
NF-Y co-associates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. 343
Dissection of the NF-Y transcriptional activation potential 343
New curcumin-derived ligands and their affinity towards Ga3+, Fe3+and Cu2+: Spectroscopic studies on complex formation and stability in solution 342
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 341
HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes 337
Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking 333
NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription 333
Ternary complex formation between MADS-box transcription factors and the histone fold protein NF-YB 328
An acetylation-mono-ubiquitination switch on lysine 120 of H2B 325
Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63 323
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 321
Switch of NF-YA splice variants in prostate cancer development and progression 320
Dysregulation of NF–Y splicing drives metabolic rewiring and aggressiveness in colon cancer 319
The interplay between NF-Y, AR and lipid metabolism regulates tumor aggressiveness in prostate cancer. 319
DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters via p53 C-terminal lysines 318
Alternative splicing of the transcription factor NF-Y promotes cell migration and invasion in colon cancer 315
Specific inhibition of NF-Y subunits triggers different cell proliferation defects. 311
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 306
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 302
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 298
Probing solute–solvent hydrogen bonding with fluorescent water-soluble curcuminoids 293
A non transcriptional role for NF-Y in DNA replication 288
Alterations in NF-Y splicing enable the metabolic plasticity of colon cancer cells and foster dynamic interactions within the tumor niche 286
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 283
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads 282
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 278
NF-YC complexity is generated by dual promoters and alternative splicing 275
Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters 272
NF-Y LOSS REACTIVATES p53 AND TRIGGERS p53-DEPENDENT APOPTOSIS IN HPV-POSITIVE HUMAN CERVICAL CARCINOMA CELLS 270
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 265
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates 264
Development of new metal-chelating multi target drus derived from Curcumin 259
The NF-YA Splicing Signature Controls Aggressiveness of Colon Cancer by Regulating Cell Metabolism and Different Types of Cell Migration 255
Direct non transcriptional role of the CCAAT-factor NF-Y in DNA replication 255
Monitoring DNA Hybridization with Organic Electrochemical Transistors Functionalized with Polydopamine 255
Role of the transcriprion factor NF-Y in cell cycle regulation 254
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 253
The NF-YA splicing signature controls aggressiveness of colon cancer by regulating different modes of cell migration and cell metabolism. 252
Development of new therapeutic Metal(III)-chelating agents derived from Curcumin 248
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 247
Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex 237
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 228
Development of new metal-based phyto-radiopharmaceuticals: diagnostic agents derived from Cur(e)cumin 228
The transcription factor NF-Y is required for satellite stem cell proliferation and skeletal muscle tissue repair 227
Development of Stable Amino-Pyrimidine–Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity 226
DNA damage promotes HDAC4 nuclear localization and G2/M promoters repression via p53 C-terminal lysisnes 226
Understanding the molecular mechanisms of Curcumin derivatives chemotherapic activity 225
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 222
Expression of the CCAAT-binding factor NF-Y in Caenorhabditis elegans 221
Investigation of transcription factor–DNA binding with electrolyte-gated organic transistors 215
Cell cycle regulation of NF-YC nuclear localization 205
In situ immunofluorescent staining of autophagy in muscle stem cells 202
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 199
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 190
Deciphering the transcriptional network of NF-Y in prostate cancer development and progression 187
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 186
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 164
Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer? 156
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 151
The transcription factor NF-Y participates in prostate cancer progression and response to androgen-deprivation therapy 151
Cross-talk between NF-Y transcription factor and m6A epitanscriptomic regulators in colon cancer: molecular characterization and clinical relevance. 139
The transcription factor NF-Y is required for satellite stem cell myogenic progression and skeletal muscle tissue repair 139
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function 132
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 124
The role(s) of NF-Y in development and differentiation 103
Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization 99
Metabolic reprogramming controlled by NF-YA alternative splicing creates therapeutic opportunities in colorectal cancer 89
Correction: Investigation of transcription factor-DNA binding with electrolyte-gated organic transistors (J. Mater. Chem. C (2024) 12 (7596–7604) DOI: 10.1039/D4TC00260A) 88
MXene‐Based Conductive Micropatterned Composites Promote Myogenic Differentiation of Muscle Cells 32
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 24
null 4
Totale 25.833
Categoria #
all - tutte 90.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.415 0 0 169 112 75 111 100 71 197 127 289 164
2022/20231.927 197 258 122 170 199 243 54 179 198 51 151 105
2023/20241.626 60 75 100 150 290 130 241 133 28 63 132 224
2024/20254.834 142 53 198 320 872 753 427 295 464 270 493 547
2025/20268.700 599 383 678 1.054 1.349 581 993 384 846 847 527 459
2026/2027877 287 575 15 0 0 0 0 0 0 0 0 0
Totale 25.833